Systematic review / meta-analysis / 2020
Taurine supplementation significantly reduced systolic and diastolic blood pressure, total cholesterol, and triglycerides in randomized controlled trials.
A meta-analysis of 12 randomized controlled trials evaluated the effects of taurine supplementation (0.5 to 6 g/d for 15 days to 6 months), primarily in patients with liver or metabolic dysregulation. Taurine significantly reduced systolic blood pressure (WMD: -4.67 mm Hg; 95% CI, -9.10 to -0.25), diastolic blood pressure (WMD: -2.90 mm Hg; 95% CI, -4.29 to -1.52), total cholesterol (WMD: -10.87 mg/dl; 95% CI, -16.96 to -4.79), and triglycerides (WMD: -13.05 mg/dl; 95% CI, -25.88 to -0.22). It had no significant effect on fasting blood glucose (WMD: 0.06 mg/dl), HDL-C (WMD: 0.90 mg/dl), LDL-C (WMD: -6.17 mg/dl), body mass index (WMD: -0.46 kg/m2), or body weight (WMD: -0.47 kg).
- Study type
- Systematic review and meta-analysis of randomized controlled trials
- Who was studied
- Patients mostly with liver or metabolic dysregulation (12 studies)
- What was measured
- Blood pressure, lipid profile, fasting blood glucose, and anthropometric measures
THE PAPER
The effects of taurine supplementation on obesity, blood pressure and lipid profile: A meta-analysis of randomized controlled trials.
Guan L, Miao P. Eur J Pharmacol, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.